Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Anti-Mullerian hormone (AMH) test information on Australian and New Zealand fertility clinic websites: a content analysis
Author: Copp, T.
Nickel, B.
Lensen, S.
Hammarberg, K.
Lieberman, D.
Doust, J.
Mol, B.W.
McCaffery, K.
Citation: BMJ Open, 2021; 11(7):e046927-1-e046927-8
Publisher: BMJ
Issue Date: 2021
ISSN: 2044-6055
Statement of
Tessa Copp, Brooke Nickel, Sarah Lensen, Karin Hammarberg, Devora Lieberman, Jenny Doust ... et al.
Abstract: Objectives The anti-Mullerian hormone (AMH) test has been promoted as a way to inform women about their future fertility. However, data consistently show the test is a poor predictor of natural fertility potential for an individual woman. As fertility centre websites are often a primary source of information for reproductive information, it is essential the information provided is accurate and reflects the available evidence. We aimed to systematically record and categorise information about the AMH test found on Australian and New Zealand fertility clinic websites. Design Content analysis of online written information about the AMH test on fertility clinic websites. Setting Accredited Australian and New Zealand fertility clinic websites. Methods Data were extracted between April and June 2020. Any webpage that mentioned the AMH test, including blogs specifically about the AMH test posted since 2015, was analysed and the content categorised. Results Of the 39 active accredited fertility clinics’ websites, 25 included information about the AMH test. The amount of information varied widely, and embodied four overarching categories; (1) the utility of the AMH test, (2) who the test is suitable for, (3) possible actions in response to the test and (4) caveats and limitations of the test. Eight specific statements about the utility of the test were identified, many of which are not evidence-based. While some websites were transparent regarding the test’s limitations, others mentioned no caveats or included persuasive statements actively promoting the test as empowering for a range of women in different circumstances. Conclusions Several websites had statements about the utility of the AMH test that are not supported by the evidence. This highlights the need for higher standards for information provided on fertility clinic websites to prevent women being misled to believe the test can reliably predict their fertility.
Keywords: Humans
New Zealand
Anti-Mullerian Hormone
Fertility Clinics
Rights: © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
DOI: 10.1136/bmjopen-2020-046927
Grant ID:
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_131838.pdf434 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.